Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience

• Published in: Anticancer research Vol. 19; no. 6C; p. 5645
• Main Authors: Semino, C, Martini, L, Queirolo, P, Cangemi, G, Costa, R, Alloisio, A, Ferlazzo, G, Sertoli, M R, Reali, U M, Ratto, G B, Melioli, G
• Format: Journal Article
• Language: English
• Published: Greece 01.11.1999
• Subjects: Clinical Trials as Topic; Humans; Immunotherapy, Adoptive; Interleukin-2 - therapeutic use; Killer Cells, Lymphokine-Activated - transplantation; Lymphocytes, Tumor-Infiltrating - transplantation; Neoplasms - mortality; Neoplasms - therapy; Outcome Assessment (Health Care); Survival Rate

Adoptive immunotherapy (AI) of cancer, based upon the injection of in vitro manipulated autologous lymphocytes is still in an experimental phase. Our group started different clinical trials of AI in early 1990, and, at present, some specific targets for this approach seem to have been identified. 29...